SCHEMBL6532407

SCHEMBL6532407

NC(=O)c1ccn(-c2cccc(-c3ccccc3)c2)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 10/20 0.63
ESRRA P11474 1/20 0.47
POLB P06746 1/20 0.42
SCN10A Q9Y5Y9 2/20 0.42
MPO P05164 1/20 0.41
TPO P07202 1/20 0.41
CYP3A4 P08684 1/20 0.41
DHODH Q02127 1/20 0.41
CYP2C9 P11712 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
FAAH O00519 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HSP90AA1 P07900 1/20 0.41
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
ATM Q13315 1/20 0.41
MGLL Q99685 1/20 0.41
COMT P21964 1/20 0.40
RPA1 P27694 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6531865 0.86 SCN9A (0.51) SCN9ADHODHCYP2C9MEN1KMT2A
SCHEMBL725497 0.86 CYP2C9 (0.53) SCN9ACYP2C9MEN1KMT2AALDH1A1
SCHEMBL7462078 0.82 PARP1 (0.53) SCN9APOLBPKMPARP1PARP2
SCHEMBL18704454 0.82 SCN9A (0.53) SCN9APOLBCYP2C9MEN1KMT2A
SCHEMBL27944386 0.76 PARP1 (0.46) SCN9APOLBCYP2C9MEN1KMT2A
SCHEMBL27787455 0.75 SCN9A (0.47) SCN9ADHODHCYP2C9MEN1KMT2A
SCHEMBL5359936 0.74 SCN9A (0.73) SCN9ASCN10ACYP3A4CYP2C9ALDH1A1
SCHEMBL5962999 0.73 SCN9A (0.51) SCN9ACYP2C9KMT2AALDH1A1MGLL
SCHEMBL14277962 0.73 RAB9A (0.49) MPOTPOCYP3A4MEN1KMT2A
SCHEMBL27648515 0.73 F7 (0.46) SCN9ACYP3A4KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO disclosed